AstraZeneca To Delist ADRs From Nasdaq By January, Eyes Broader Investor Reach

AstraZeneca Plc (NASDAQ:AZN) said Tuesday it will voluntarily delist its American Depositary Shares and certain guaranteed debt securities from the Nasdaq as it transitions to a direct stock listing on the New York Stock Exchange (NYSE).The company previously announced that its ordinary shares and the affected debt securities will begin trading on the NYSE following market close on January 30, 2026, with trading expected to start on February 2, 2026. The Nasdaq listings are expected to cease on January 30.T ...